Q fever vaccine research
Q fever consortium led by MGH
The US government sees Q fever is a serious threat and is investing in the development of a new Q fever vaccine. To develop an effective vaccine, knowledge on the immune response to the infectious disease, and which parts of the bacterium caused that effect, is very important. This methods developed by Innatoss Laboratories support such research.
Therefore our company has entered the QVaxcelerate consortium led by Massachusetts General Hospital, funded by the US Defense Threat Reduction Agency. Other participants are Yale University and EpiVax, among others.
Mass. General-led consortium focusing on rapid development of Q fever vaccine